Status:
COMPLETED
Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study
Lead Sponsor:
Brahms AG
Conditions:
Patients Presenting With Suspicion of Infection to the ED
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that ...
Eligibility Criteria
Inclusion
- Consecutive patients presenting to the ED with suspicion of infection
- Age ≥18 years
- Written Informed Consent obtained
Exclusion
- Recent major trauma or surgery
- End stage renal failure requiring dialysis
- Terminal disease and/or very severe medical co-morbidity where death has to be expected in the next 6 months, e.g. due to malignancy, cardiac, renal or hepatic failure
- Patients those source of infection always requires hospital admission or never requires hospital admission.
- Patients who cannot be discharged for other than medical reasons
- Patient participates in any other interventional clinical trial
- Patients with active intravenous drug use
- Pregnant or lactating women
- Patients who are institutionalized by official or judicial order
- Dependents of the sponsor, the CRO, the study site or the investigator
Key Trial Info
Start Date :
December 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03770533
Start Date
December 14 2018
End Date
December 11 2019
Last Update
December 12 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain, 33011
2
Hospital Universitario de Bellvitge
Barcelona, Spain, 08907
3
Hospital Clínico San Carlos
Madrid, Spain, 28040
4
Hospital Virgen Macarena
Seville, Spain, 41009